GET THE APP

An analytical method development and validation for simultaneous estimation of Sumatriptan and Naproxen in bulk samples as well as in tablet dosage forms by using RP-HPLC | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

An analytical method development and validation for simultaneous estimation of Sumatriptan and Naproxen in bulk samples as well as in tablet dosage forms by using RP-HPLC

Author(s): Manidipa Debnath, S. Ashutosh Kumar, Durga Pavani Anguluri, G. Poorna Sri Ramya, J. V. L. N. Seshagiri Rao and D. Gowri Sankar

The present work was undertaken with the aim to develop and validate a rapid and consistent RP-HPLC method in which the peaks will be appear with short period of time as per ICH Guidelines. The HPLC separation was achieved on a Kromosil -ODS C18 (250 X 4.6 mm; 5 μ) column in an Isocratic Mode. The mobile phase composed of Water [HPLC Grade] (45 %) [pH 2.5 adjusted with OPA] and Methanol (55 %). The flow rate was monitored at 1.0 mL/min. The wavelength was selected for the detection was 277 nm. The retention times found for Sumatriptan and Naproxen was 2.790 and 3.481 min respectively. The % recovery was 99.02- 100.75 for Sumatriptan and 99.85 - 100.22 for Naproxen. The linearity was established in the range of 20-80 μg/mL for both Sumatriptan and Naproxen. The LOD for Sumatriptan and Naproxen were 0.56 and 0.57 μg/mL respectively. The LOQ for Sumatriptan and Naproxen were 1.69 and 1.74 μg/mL respectively. The proposed method was adequate sensitive, reproducible, and specific for the determination of Sumatriptan and Naproxen in bulk as well as in tablet dosage forms.